glp-1 anorexia #504: Adult Eating Disorders in the Era GLP-1 obesity drugs and eating

GLP-1 and gallbladder risk is real but modest

Among regular drinkers, consumption plummeted from 23.2 to 7.8 units per week a 68 percent reduction, which Professor le Roux noted is comparable to that achieved by nalmefene, a drug used to treat alcohol use disorder in Europe. The potential for these weight loss drugs to reduce alcohol consumption could yield additional public health and economic benefits

p<0.01) and waist circumference (MD 3.84cm

Bottom line: GLP-1s opened the door by proving obesity therapies can be CV disease interventions

Get clarity on Appetite changes: how Mounjaro (tirzepatide) fits in appetite, results key takeaways and FAQs

Perioperative Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) and Gastric Point Of Care Ultrasound (POCUS) Published by POCUS Journal